Clinical trial
Study of Mometasone Furoate/Formoterol Fumarate Inhalation Combination in…
NCT00418509 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00418509 |
|---|---|
| Title | Study of Mometasone Furoate/Formoterol Fumarate Inhalation Combination in Healthy Volunteers |
| Official title | A Randomized, Single Dose, 3-Period Crossover Study to Evaluate the Dosage Form Proportionality, Dose Proportionality and Pharmacokinetics of Mometasone Furoate and Formoterol Fumarate From Three Combination MDI Formulations |
| Lead sponsor | Novartis, Industry |
| Collaborators | Schering-Plough Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | Mometasone furoate, Formoterol fumarate |
| Enrollment | 24 |
| Start date | Nov 1, 2006 |
| First posted | Jan 5, 2007 |
| Last update posted | Jun 22, 2007 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: